PUBLISHER: GlobalData | PRODUCT CODE: 1131811
PUBLISHER: GlobalData | PRODUCT CODE: 1131811
This 55-page PowerPoint based report gives an important update to the previous year with an expert analysis on how COVID-19 is impacting clinical trials and the potential move toward decentralized clinical trials. Findings are based on a survey conducted with respondents from around the world that belonged to Pharma/Biotech, Government/Academic Institutions, CROs, CMOs, or other contract service providers. The report includes:
Study Design and Key Findings.
Primary Concerns, which include business concerns, clinical trial concerns for decentralized clinical trials and addressing trial disruption.
Movement Toward Decentralized Trials, including pre and post pandemic decentralized clinical trials use, future movement toward using decentralized clinical trials and cost comparison.
Challenges Facing Decentralized Trials, which explores the biggest challenges, changes, considerations and risk deviations for decentralized clinical trials.